Detalhe da pesquisa
1.
Persistence of monoclonal B-cell expansion and intraclonal diversification despite virus eradication in patients affected by hepatitis C virus-associated lymphoproliferative disorders.
Br J Haematol
; 203(2): 237-243, 2023 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-37491625
2.
A laboratory-based scoring system predicts early treatment in Rai 0 chronic lymphocytic leukemia.
Haematologica
; 105(6): 1613-1620, 2020 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-31582547
3.
Immunoglobulin kappa deleting element rearrangements are candidate targets for minimal residual disease evaluation in mantle cell lymphoma.
Hematol Oncol
; 38(5): 698-704, 2020 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-32816326
4.
Minimal residual disease (MRD) in non-Hodgkin lymphomas: Interlaboratory reproducibility on marrow samples with very low levels of disease within the FIL (Fondazione Italiana Linfomi) MRD Network.
Hematol Oncol
; 37(4): 368-374, 2019 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-31325190
5.
Transcriptomics and Immunological Analyses Reveal a Pro-Angiogenic and Anti-Inflammatory Phenotype for Decidual Endothelial Cells.
Int J Mol Sci
; 20(7)2019 Mar 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-30935090
6.
Association between molecular lesions and specific B-cell receptor subsets in chronic lymphocytic leukemia.
Blood
; 121(24): 4902-5, 2013 Jun 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-23637131
7.
A B-cell receptor-related gene signature predicts response to ibrutinib treatment in mantle cell lymphoma cell lines.
Haematologica
; 104(9): e410-e414, 2019 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-30819916
8.
NOTCH1 mutational status in chronic lymphocytic leukaemia: clinical relevance of subclonal mutations and mutation types.
Br J Haematol
; 182(4): 597-602, 2018 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-28699643
9.
Mutations in the 3' untranslated region of NOTCH1 are associated with low CD20 expression levels chronic lymphocytic leukemia.
Haematologica
; 102(8): e305-e309, 2017 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-28550186
10.
Mutational status of IGHV is the most reliable prognostic marker in trisomy 12 chronic lymphocytic leukemia.
Haematologica
; 102(11): e443-e446, 2017 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-28751560
11.
Gene expression in regenerating and scarring tails of lizard evidences three main key genes (wnt2b, egfl6, and arhgap28) activated during the regulated process of tail regeneration.
Protoplasma
; 258(1): 3-17, 2021 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-32852660
12.
TP53 Mutations with Low Variant Allele Frequency Predict Short Survival in Chronic Lymphocytic Leukemia.
Clin Cancer Res
; 27(20): 5566-5575, 2021 10 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-34285062
13.
Prognostic impact of ZAP-70 expression in chronic lymphocytic leukemia: mean fluorescence intensity T/B ratio versus percentage of positive cells.
J Transl Med
; 8: 23, 2010 Mar 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-20211015
14.
Molecular and clinical features of chronic lymphocytic leukaemia with stereotyped B cell receptors: results from an Italian multicentre study.
Br J Haematol
; 144(4): 492-506, 2009 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-19036101
15.
Hyaluronan-CD44 interaction hampers migration of osteoclast-like cells by down-regulating MMP-9.
J Cell Biol
; 158(6): 1133-44, 2002 Sep 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-12235127
16.
ARHGDIA, a mutant TP53-associated Rho GDP dissociation inhibitor, is over-expressed in gene expression profiles of TP53 disrupted chronic lymphocytic leukaemia cells.
Br J Haematol
; 161(4): 596-9, 2013 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-23406297
17.
Clinical significance of c.7544-7545 delCT NOTCH1 mutation in chronic lymphocytic leukaemia.
Br J Haematol
; 160(3): 415-8, 2013 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-23167503
18.
Clinical impact of TP53 disruption in chronic lymphocytic leukemia patients treated with ibrutinib: a campus CLL study.
Leukemia
; 37(4): 914-918, 2023 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36807650
19.
Laminin-332 (Laminin-5) is the major motility ligand for B cell chronic lymphocytic leukemia.
Matrix Biol
; 26(6): 473-84, 2007 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-17482449
20.
Surface-antigen expression profiling of B cell chronic lymphocytic leukemia: from the signature of specific disease subsets to the identification of markers with prognostic relevance.
J Transl Med
; 4: 11, 2006 Mar 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-16509989